两个审稿人,一个同意发表,一个拒稿,有没有必要argue一下呢?
这是具体审稿意见,感觉都没提出什么具体问题,第二位审稿人主要就是质疑创新性,大家给看看有没有必要argue呢?如果有必要该怎么写呢?第一次遇到这种情况,希望有经验的可以多多指导!谢谢!
In view of the criticisms of the reviewer(s) found at the bottom of this letter, your manuscript has been denied publication in the *****.
Reviewer(s)' Comments to Author:
Reviewer: 1
Comments to the Author
In this paper, the authors gave some experimental proofs and explained the reasons on the compatibilizing agent A has better interfacial adhesion properties than B between PP and MOSw. The authors investigated the effects of compatibilizing agent on the interfacial adhesion properties of the PP/MOSw composites by SEM, TGA, ATR-FTIR and rheological tests in detailed. Besides these techniques, DSC results maybe provide some useful information on this topic. The paper is well-written and can be accepted for publication in ****.
Reviewer: 2
Comments to the Author
The authors studied effects of A and B on interfacial adhesion properties of the PP/MOSw composites. Although the manuscript does not contain significant technical flaws, it lacks the sense of innovation in terms of material preparation, characterization, and discussion. The topic dealing with interfacial interaction of PP composites has been substantially investigated, and the conclusions are known to the community. Mechanism analysis is routine and does not add to existing understanding of similar systems. In this context, the manuscript is more suitable for journals focusing on polymer engineering.
返回小木虫查看更多
京公网安备 11010802022153号
改投别的杂志更好一些 argue也不一定有用 也许还浪费时间
有拒稿意见的没必要argue,成功率极低
建议argue一下,还是有希望的,北航那篇nature也是argue争取才发表的,可能也就耽误一到两周而已
,
我觉得再解释不如按照审稿意见修改一点找个别的期刊投!已经没希望了,别浪费时间!
argue的话你的point是什么呢?创新性这东西有时候仁者见仁,没法定量衡量。除非你有什么有力的证据说明你的创新性
改投吧,审稿人2也说了,建议换个更合适的期刊